July 6, 2017
MADRID — Pregnant patients with antiphospholipid syndrome managed with conventional treatments appear to have a high level of obstetrical complications and may benefit from the addition of aspirin to their regimen, according to a study presented at the EULAR Annual Congress.
“We report a high level of obstetrical complication in these patients, despite treatment,” presenter Cecile M. Yelnik, MD, said. “We also found a beneficial effect of adding aspirin to prevent obstetric morbidity. Heparin and aspirin were well tolerated and did not increase risk of hemorrhage. A therapeutic trial is needed to confirm the safety profile.”